Drug

Emtricitabine tenofovir alafenamide clinical trials

studies test it: 20
open now: 2
in phase 3: 5
first study started: 2014

Keep track of what changes. Save the emtricitabine tenofovir alafenamide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Descovy: 10
Emtricitabine/Tenofovir Alafenamide: 3
FTC/TAF: 3
Descovy® (TAF/FTC): 2

Studies by the year they started

20 studies that test it; most in 2020 (4)

Studies that test emtricitabine tenofovir alafenamide, by start year
Year	Studies
2014	1
2015	2
2016	1
2017	3
2020	4
2021	2
2022	3
2023	1
2024	2
2025	1

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 5
Phase 2: 5
Phase 3: 5
Phase 4: 5
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it.

Acquired Immunodeficiency Syndrome: 2
HIV Infections: 2
Cognitive Dysfunction: 1
Osteoporosis: 1
COVID-19: 1

Who runs them

Industry 6 · Other 14

Gilead Sciences (3) · National University Hospital, Singapore (1) · University of Washington (1) · University of Miami (1) · Vivent Health (1) · Janssen Research & Development, LLC (1) · MRC/UVRI and LSHTM Uganda Research Unit (1) · University Health Network, Toronto (1)

Often tested with

Tested in the same studies.

Emtricitabine (7) · Darunavir (5) · Cobicistat (5) · Tenofovir alafenamide (5) · Tenofovir (3) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · Atazanavir (2) · Elvitegravir (2)

Studies

Open first, then newest update. How each study uses emtricitabine tenofovir alafenamide is read from its arms, and is right about nine times in ten.

Testing it · 20

Given in every arm · 5 — emtricitabine tenofovir alafenamide is usual care beside what is tested

As the comparator · 3 — what is tested is compared with emtricitabine tenofovir alafenamide

Codes

What other systems call emtricitabine tenofovir alafenamide · ClinicalTrials.gg INT000591

MeSH (NLM) C000613801emtricitabine tenofovir alafenamideOne source ClinicalTrials.gov

System	Code	Name there	Checked by
MeSH (NLM)	C000613801	emtricitabine tenofovir alafenamide	One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.